Patents by Inventor Charlotta Lindvall

Charlotta Lindvall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11915828
    Abstract: A method for autonomously identifying symptom terms in free running text data includes the acts of defining a plurality of symptom terms associated with a particular pathology or therapeutic substance or procedure, labeling in a text data set any defined symptom terms and associating a tag indicating any of a positive, negative, or other status with relation to the labeled symptom term, and processing with a natural language processing algorithm multiple different subsets of the text data containing labeled symptom terms to identify a frequency of occurrence of a symptom term and to improve identification accuracy.
    Type: Grant
    Filed: June 3, 2020
    Date of Patent: February 27, 2024
    Assignee: DANA-FARBER CANCER INSTITUTE, INC.
    Inventor: Charlotta Lindvall
  • Publication number: 20200388396
    Abstract: A method for autonomously identifying symptom terms in free running text data includes the acts of defining a plurality of symptom terms associated with a particular pathology or therapeutic substance or procedure, labeling in a text data set any defined symptom terms and associating a tag indicating any of a positive, negative, or other status with relation to the labeled symptom term, and processing with a natural language processing algorithm multiple different subsets of the text data containing labeled symptom terms to identify a frequency of occurrence of a symptom term and to improve identification accuracy.
    Type: Application
    Filed: June 3, 2020
    Publication date: December 10, 2020
    Applicant: DANA-FARBER CANCER INSTITUTE, INC.
    Inventor: Charlotta Lindvall
  • Patent number: 7622267
    Abstract: A method for enriching a population of somatic mammary stem cells or mammary tumor stem cells based on low-density lipoprotein receptor-related protein 6 (LRP6). Also included are methods for screening for LRP6 modulators, as well as methods for reducing Wnt signaling, for treating Wnt signaling-related diseases, for detecting mammary basal-like cells, for diagnosing basal-like breast cancer, and for inhibiting proliferation of a tumor expressing LRP6, and compositions thereof.
    Type: Grant
    Filed: May 30, 2007
    Date of Patent: November 24, 2009
    Assignee: Van Andel Research Institute
    Inventors: Bart O. Williams, Charlotta Lindvall
  • Patent number: 7563619
    Abstract: It is disclosed here that low density lipoprotein receptor-related protein 5 (LRP5) is a cell surface marker for somatic mammary stem cells and mammary tumor stem cells. The disclosure here provides new tools for enriching somatic mammary stem cells and mammary tumor stem cells. Methods of screening for agents that modulate LRP5 activity, of treating mammary tumor or breast cancer, of monitoring somatic mammary stem cells and mammary tumor stem cells in vivo are also provided, and of assessing prognosis of human breast cancer.
    Type: Grant
    Filed: May 30, 2007
    Date of Patent: July 21, 2009
    Assignees: Van Andel Research Institute, Wisconsin Alumni Research Foundation
    Inventors: Bart Williams, Caroline M. Alexander, Charlotta Lindvall, Nisha McConnell
  • Publication number: 20070292348
    Abstract: A method for enriching a population of somatic mammary stem cells or mammary tumor stem cells based on low-density lipoprotein receptor-related protein 6 (LRP6). Also included are methods for screening for LRP6 modulators, as well as methods for reducing Wnt signaling, for treating Wnt signaling-related diseases, for detecting mammary basal-like cells, for diagnosing basal-like breast cancer, and for inhibiting proliferation of a tumor expressing LRP6, and compositions thereof.
    Type: Application
    Filed: May 30, 2007
    Publication date: December 20, 2007
    Inventors: Bart Williams, Charlotta Lindvall
  • Publication number: 20070280948
    Abstract: It is disclosed here that low density lipoprotein receptor-related protein 5 (LRP5) is a cell surface marker for somatic mammary stem cells and mammary tumor stem cells. The disclosure here provides new tools for enriching somatic mammary stem cells and mammary tumor stem cells. Methods of screening for agents that modulate LRP5 activity, of treating mammary tumor or breast cancer, of monitoring somatic mammary stem cells and mammary tumor stem cells in vivo are also provided, and of assessing prognosis of human breast cancer.
    Type: Application
    Filed: May 30, 2007
    Publication date: December 6, 2007
    Inventors: Bart Williams, Caroline Alexander, Charlotta Lindvall, Nisha McConnell